Gary D. Hodgen
23Patents
13h-index
9Co-inventors
74Inventor score
Filing activity: Nov 30, 1981 → Dec 20, 2004
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4413985A | Hydrocephalic antenatal vent for intrauterine treatment (HAVIT) | Human Necessities | 88 | Expired |
| US5468736A | Hormone replacement therapy | Human Necessities | 76 | Expired |
| US5681817A | Treatment of ovarian estrogen dependent conditions | Human Necessities | 61 | Expired |
| US7704983B1 | Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception | Human Necessities | 53 | Expired |
| US5219729A | Fertility assay | Emerging Cross-Sectional Technologies | 49 | Expired |
| US5898032A | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy | Human Necessities | 38 | Expired |
| US5552394A | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy | Human Necessities | 35 | Expired |
| US5180711A | Combined treatment with GnRH antagonist and GnRH to control gonadotropin levels in mammals | Human Necessities | 30 | Expired |
| US5691314A | Adjunctive therapy | Human Necessities | 29 | Expired |
| US5824286A | Mammography method | Human Necessities | 15 | Expired |
| USRE39861E1 | Methods of extended use oral contraception | General | 15 | Expired |
| US4589402A | Method of in vitro fertilization | Human Necessities | 13 | Expired |
| US4845077A | Method of inducing ovulation | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6653297B1 | Control of selective estrogen receptor modulators | Human Necessities | 10 | Expired |
| US5622943A | Minimizing progestin associated breakthrough bleeding | Human Necessities | 7 | Expired |
| US5516769A | Method of inhibiting fertilization | Human Necessities | 6 | Expired |
| US5658884A | Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens | Human Necessities | 5 | Expired |
| US5116818A | Method and kit for contraception with GnRH-antagonist | Emerging Cross-Sectional Technologies | 5 | Expired |
| US4740364A | Predicting predisposition to osteoporosis | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6258802A | Corticoid therapy | Human Necessities | 1 | Expired |
| US7256185B1 | Control of selective estrogen receptor modulators | Human Necessities | 0 | Expired |
| US7538099B1 | Antiprogestin method and kit for reducing side effects associated with low dosage HRT, oral contraception and regulating menses | Human Necessities | 0 | Expired |
| USRE40119E1 | Adjunctive therapy | General | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.